Company

Pinnacle Medicines, Inc.

Pinnacle Medicines develops oral peptide therapeutics for chronic diseases.

About

Pinnacle Medicines develops oral peptide therapies for chronic diseases with unmet medical needs. Founded in 2024, the company is based in Doylestown, US. It has completed two deals, including a Series B round of USD 89.00 mn from Foresite Capital and RA Capital Management.

1Funding rounds

7Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in